Heart drugs may boost recovery after valve surgery
NCT ID NCT07539259
First seen Jun 27, 2026 · Last updated Jul 14, 2026 · Updated 2 times
Summary
This study tests whether two heart failure medications, dapagliflozin and spironolactone, can help the heart recover better after aortic valve replacement. About 445 adults with severe aortic stenosis will take one or both drugs daily for 12 months. The goal is to see if these medicines reduce heart muscle thickness and scarring, improving long-term heart function.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC STENOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI ultrasound could unmask silent heart disease in seniors
- Heart valve fix without the hospital stay? trial tests Same-Day discharge
- Can a wearable monitor prevent heart emergencies after valve replacement?
- Mountain air or heart risk? trial asks if high altitude is safe for aortic stenosis patients.
- Blood test could predict clot risk after heart valve surgery
- AI-Powered ultrasound could spot hidden heart valve disease in minutes